United States Cardiovascular Procedures Outlook to 2020

Publisher Name :
Date: 30-May-2014
No. of pages: 176

GlobalData’s new report, “United States Cardiovascular Procedures Outlook to 2020″, provides key procedures data on the United States Cardiovascular Procedures. The report provides procedure volumes within market categories Cardiac Assist Procedures, Cardiovascular Surgery, Electrophysiology Procedures, Cardiac Rhythm Management (CRM) Procedures, Interventional Cardiology Procedures, Cardiovascular Prosthetic Procedures, Prosthetic Heart Valve Procedures and Peripheral Vascular Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

  • Procedure volumes data for Cardiovascular market categories Cardiac Assist Procedures, Cardiovascular Surgery, Electrophysiology Procedures, Cardiac Rhythm Management (CRM) Procedures, Interventional Cardiology Procedures, Cardiovascular Prosthetic Procedures, Prosthetic Heart Valve Procedures and Peripheral Vascular Procedures.
  • Projections for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.

Reasons to buy

  • Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Develop market-entry and market expansion strategies.

United States Cardiovascular Procedures Outlook to 2020

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7

2 Introduction 9
2.1 What Is This Report About? 9
2.2 Cardiovascular Procedures, Segmentation 9
2.3 Definitions of Procedures Covered in the Report 12

3 Cardiovascular Procedures, United States 22
3.1 Cardiovascular Procedures, United States, 2005-2020 22
3.2 Cardiovascular Procedures, United States, Category Comparison by Procedures, 2005-2020 24
3.3 Cardiovascular Procedures, United States, 2005-2012 26
3.4 Cardiovascular Procedures, United States, 2012-2020 28

4 Cardiac Assist Procedures, United States 30
4.1 Cardiac Assist Procedures, United States, 2005-2012 30
4.2 Cardiac Assist Procedures, United States, 2012-2020 32
4.2.1 Ventricular Assist Devices (VAD) Procedures, United States, 2005-2012 34
4.2.2 Ventricular Assist Devices (VAD) Procedures, United States, 2012-2020 36

5 Cardiac Rhythm Management (CRM) Procedures, United States 38
5.1 Cardiac Rhythm Management (CRM) Procedures, United States, 2005-2012 38
5.2 Cardiac Rhythm Management (CRM) Procedures, United States, 2012-2020 40
5.2.1 Implantable Cardioverter Defibrillator (ICD) Procedures, United States, 2005-2012 42
5.2.1.1 CRT Single Chamber ICD Procedures, United States, 2005-2012 44
5.2.1.2 CRT Dual Chamber ICD Procedures, United States, 2005-2012 46
5.2.2 Cardiac Resynchronisation Therapy (CRT) Procedures, United States, 2005-2012 48
5.2.2.1 CRT - Defibrillator Implant Procedures, United States, 2005-2012 50
5.2.2.2 CRT - Pacemaker Implant Procedures, United States, 2005-2012 52
5.2.3 Pacemaker Implant Procedures, United States, 2005-2012 54
5.2.3.1 Single chamber Pacemaker Implant Procedures, United States, 2005-2012 56
5.2.3.2 Dual chamber Pacemaker Implant Procedures, United States, 2005-2012 58
5.2.4 Implantable Loop Recorder (ILR) Procedures, United States, 2005-2012 60
5.2.5 Implantable Cardioverter Defibrillator (ICD) Procedures, United States, 2012-2020 62
5.2.5.1 Single Chamber ICD Procedures, United States, 2012-2020 64
5.2.5.2 Dual Chamber ICD Procedures, United States, 2012-2020 66
5.2.6 Cardiac Resynchronisation Therapy (CRT) Procedures, United States, 2012-2020 68
5.2.6.1 CRT - Defibrillator Implant Procedures, United States, 2012-2020 70
5.2.6.2 CRT - Pacemaker Implant Procedures, United States, 2012-2020 72
5.2.7 Pacemaker Implant Procedures, United States, 2012-2020 74
5.2.7.1 Single chamber Pacemaker Implant Procedures, United States, 2012-2020 76
5.2.7.2 Dual chamber Pacemaker Implant Procedures, United States, 2012-2020 78
5.2.8 Implantable Loop Recorder (ILR) Procedures, United States, 2012-2020 80

6 Cardiovascular Prosthetic Procedures, United States 82
6.1 Septal Occluders, United States, 2005-2012 82
6.2 Septal Occluders, United States, 2012-2020 84

7 Cardiovascular Surgery, United States 86
7.1 Cardiovascular Surgery, United States, 2005-2012 86
7.2 Cardiovascular Surgery, United States, 2012-2020 88
7.2.1 Coronary Artery Bypass Graft Procedures (CABG), United States, 2005-2012 90
7.2.2 On Pump Procedures, United States, 2005-2012 92
7.2.3 Coronary Artery Bypass Graft Procedures (CABG), United States, 2012-2020 94
7.2.4 On Pump Procedures, United States, 2012-2020 96

8 Electrophysiology Procedures, United States 98
8.1 Electrophysiology Ablation Procedures, United States, 2005-2012 98
8.2 Electrophysiology Ablation Procedures, United States, 2012-2020 99

9 Interventional Cardiology Procedures, United States 100
9.1 Interventional Cardiology Procedures, United States, 2005-2012 100
9.2 Interventional Cardiology Procedures, United States, 2012-2020 102
9.2.1 Coronary Stenting Procedures, United States, 2005-2012 104
9.2.2 Coronary Stenting Procedures, United States, 2012-2020 106
9.2.2.1 Bare Metal Coronary Stenting Procedures, United States, 2005-2012 108
9.2.2.2 Drug Eluting Coronary Stenting Procedures, United States, 2005-2012 110
9.2.2.3 Bare Metal Coronary Stenting Procedures, United States, 2012-2020 112
9.2.2.4 Drug Eluting Coronary Stenting Procedures, United States, 2012-2020 114

10 Peripheral Vascular Procedures, United States 116
10.1 Peripheral Vascular Procedures, United States, 2005-2012 116
10.2 Peripheral Vascular Procedures, United States, 2012-2020 119
10.2.1 Peripheral Vascular Stenting Procedures, United States, 2005-2012 122
10.2.1.1 Iliac Artery Stenting Procedures, United States, 2005-2012 124
10.2.1.2 Femoropopliteal Artery Stenting Procedures, United States, 2005-2012 126
10.2.1.3 Infrapopliteal Artery Stenting Procedures, United States, 2005-2012 128
10.2.2 PTA Balloon Angioplasty Procedures, United States, 2005-2012 130
10.2.3 Aortic Stent Graft Procedures, United States, 2005-2012 132
10.2.4 Aortic Open Repair Procedures, United States, 2005-2012 134
10.2.5 Peripheral Bypass Procedures, United States, 2005-2012 136
10.2.6 PTA Drug Eluting Balloons (DEB) Angioplasty Procedures, United States, 2012-2020 138
10.2.7 Peripheral Vascular Stenting Procedures, United States, 2012-2020 140
10.2.7.1 Iliac Artery Stenting Procedures, United States, 2012-2020 142
10.2.7.2 Femoropopliteal Artery Stenting Procedures, United States, 2012-2020 144
10.2.7.3 Infrapopliteal Artery Stenting Procedures, United States, 2012-2020 146
10.2.8 PTA Balloon Angioplasty Procedures, United States, 2012-2020 148
10.2.9 Aortic Stent Graft Procedures, United States, 2012-2020 150
10.2.10 Aortic Open Repair Procedures, United States, 2012-2020 152
10.2.11 Peripheral Bypass Procedures, United States, 2012-2020 154

11 Prosthetic Heart Valve Procedures, United States 156
11.1 Prosthetic Heart Valve Procedures, United States, 2005-2012 156
11.2 Prosthetic Heart Valve Procedures, United States, 2012-2020 158
11.2.1 Conventional Aortic Valve Replacement Procedures, United States, 2005-2012 160
11.2.2 Conventional Mitral Valve Procedures, United States, 2005-2012 162
11.2.3 Conventional Aortic Valve Replacement Procedures, United States, 2012-2020 164
11.2.4 Conventional Mitral Valve Procedures, United States, 2012-2020 166

12 Appendix 168
12.1 Research Methodology 169
12.1.1 Coverage 169
12.1.2 Secondary Research 169
12.1.3 Primary Research 170
12.1.4 Market Modeling and Forecasting 171
12.1.5 Company Share Analysis 174
12.1.6 Distribution Share Analysis 175
12.2 Expert Panel 175
12.3 GlobalData Consulting 176
12.4 Contact Us 176
12.5 Disclaimer 176

List of Tables

Table 1: Cardiovascular Procedures, United States, 2005-2020 23
Table 2: Cardiovascular Procedures, United States, Category Comparison by Procedures, 2005-2020 25
Table 3: Cardiovascular Procedures, United States, Historic, 2005-2012 27
Table 4: Cardiovascular Procedures, United States, Forecast, 2012-2020 29
Table 5: Cardiac Assist Procedures, United States, Historic, 2005-2012 31
Table 6: Cardiac Assist Procedures, United States, Forecast, 2012-2020 33
Table 7: Ventricular Assist Devices (VAD) Procedures, United States, Historic, 2005-2012 35
Table 8: Ventricular Assist Devices (VAD) Procedures, United States, Forecast, 2012-2020 37
Table 9: Cardiac Rhythm Management (CRM) Procedures, United States, Historic, 2005-2012 39
Table 10: Cardiac Rhythm Management (CRM) Procedures, United States, Forecast, 2012-2020 41
Table 11: Implantable Cardioverter Defibrillator (ICD) Procedures, United States, Historic, 2005-2012 43
Table 12: Single Chamber ICD Procedures, United States, Historic, 2005-2012 45
Table 13: Dual Chamber ICD Procedures, United States, Historic, 2005-2012 47
Table 14: Cardiac Resynchronisation Therapy (CRT) Procedures, United States, Historic, 2005-2012 49
Table 15: CRT - Defibrillator Implant Procedures, United States, Historic, 2005-2012 51
Table 16: CRT - Pacemaker Implant Procedures, United States, Historic, 2005-2012 53
Table 17: Pacemaker Implant Procedures, United States, Historic, 2005-2012 55
Table 18: Single chamber Pacemaker Implant Procedures, United States, Historic, 2005-2012 57
Table 19: Dual chamber Pacemaker Implant Procedures, United States, Historic, 2005-2012 59
Table 20: Implantable Loop Recorder (ILR) Procedures, United States, Historic, 2005-2012 61
Table 21: Implantable Cardioverter Defibrillator (ICD) Procedures, United States, Forecast, 2012-2020 63
Table 22: Single Chamber ICD Procedures, United States, Forecast, 2012-2020 65
Table 23: Dual Chamber ICD Procedures, United States, Forecast, 2012-2020 67
Table 24: Cardiac Resynchronisation Therapy (CRT) Procedures, United States, Forecast, 2012-2020 69
Table 25: CRT - Defibrillator Implant Procedures, United States, Forecast, 2012-2020 71
Table 26: CRT - Pacemaker Implant Procedures, United States, Forecast, 2012-2020 73
Table 27: Pacemaker Implant Procedures, United States, Forecast, 2012-2020 75
Table 28: Single chamber Pacemaker Implant Procedures, United States, Forecast, 2012-2020 77
Table 29: Dual chamber Pacemaker Implant Procedures, United States, Forecast, 2012-2020 79
Table 30: Implantable Loop Recorder (ILR) Procedures, United States, Forecast, 2012-2020 81
Table 31: Septal Occluders, United States, Historic, 2005-2012 83
Table 32: Septal Occluders, United States, Forecast, 2012-2020 85
Table 33: Cardiovascular Surgery, United States, Historic, 2005-2012 87
Table 34: Cardiovascular Surgery, United States, Forecast, 2012-2020 89
Table 35: Coronary Artery Bypass Graft Procedures (CABG), United States, Historic, 2005-2012 91
Table 36: On Pump Procedures, United States, Historic, 2005-2012 93
Table 37: Coronary Artery Bypass Graft Procedures (CABG), United States, Forecast, 2012-2020 95
Table 38: On Pump Procedures, United States, Forecast, 2012-2020 97
Table 39: Electrophysiology Ablation Procedures, United States, Historic, 2005-2012 98
Table 40: Electrophysiology Ablation Procedures, United States, Forecast, 2012-2020 99
Table 41: Interventional Cardiology Procedures, United States, Historic, 2005-2012 101
Table 42: Interventional Cardiology Procedures, United States, Forecast, 2012-2020 103
Table 43: Coronary Stenting Procedures, United States, Historic, 2005-2012 105
Table 44: Coronary Stenting Procedures, United States, Forecast, 2012-2020 107
Table 45: Bare Metal Coronary Stenting Procedures, United States, Historic, 2005-2012 109
Table 46: Drug Eluting Coronary Stenting Procedures, United States, Historic, 2005-2012 111
Table 47: Bare Metal Coronary Stenting Procedures, United States, Forecast, 2012-2020 113
Table 48: Drug Eluting Coronary Stenting Procedures, United States, Forecast, 2012-2020 115
Table 49: Peripheral Vascular Procedures, United States, Historic, 2005-2012 117
Table 50: Peripheral Vascular Procedures, United States, Forecast, 2012-2020 120
Table 51: Peripheral Vascular Stenting Procedures, United States, Historic, 2005-2012 123
Table 52: Iliac Artery Stenting Procedures, United States, Historic, 2005-2012 125
Table 53: Femoropopliteal Artery Stenting Procedures, United States, Historic, 2005-2012 127
Table 54: Infrapopliteal Artery Stenting Procedures, United States, Historic, 2005-2012 129
Table 55: PTA Balloon Angioplasty Procedures, United States, Historic, 2005-2012 131
Table 56: Aortic Stent Graft Procedures, United States, Historic, 2005-2012 133
Table 57: Aortic Open Repair Procedures, United States, Historic, 2005-2012 135
Table 58: Peripheral Bypass Procedures, United States, Historic, 2005-2012 137
Table 59: PTA Drug Eluting Balloons (DEB) Angioplasty Procedures, United States, Forecast, 2012-2020 139
Table 60: Peripheral Vascular Stenting Procedures, United States, Forecast, 2012-2020 141
Table 61: Iliac Artery Stenting Procedures, United States, Forecast, 2012-2020 143
Table 62: Femoropopliteal Artery Stenting Procedures, United States, Forecast, 2012-2020 145
Table 63: Infrapopliteal Artery Stenting Procedures, United States, Forecast, 2012-2020 147
Table 64: PTA Balloon Angioplasty Procedures, United States, Forecast, 2012-2020 149
Table 65: Aortic Stent Graft Procedures, United States, Forecast, 2012-2020 151
Table 66: Aortic Open Repair Procedures, United States, Forecast, 2012-2020 153
Table 67: Peripheral Bypass Procedures, United States, Forecast, 2012-2020 155
Table 68: Prosthetic Heart Valve Procedures, United States, Historic, 2005-2012 157
Table 69: Prosthetic Heart Valve Procedures, United States, Forecast, 2012-2020 159
Table 70: Conventional Aortic Valve Replacement Procedures, United States, Historic, 2005-2012 161
Table 71: Conventional Mitral Valve Procedures, United States, Historic, 2005-2012 163
Table 72: Conventional Aortic Valve Replacement Procedures, United States, Forecast, 2012-2020 165
Table 73: Conventional Mitral Valve Procedures, United States, Forecast, 2012-2020 167
Table 74: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 171

List of Figures

Figure 1: Cardiovascular Procedures, United States, 2005-2020 22
Figure 2: Cardiovascular Procedures, United States, Category Comparison by Procedures, 2005-2020 24
Figure 3: Cardiovascular Procedures, United States, Historic, 2005-2012 26
Figure 4: Cardiovascular Procedures, United States, Forecast, 2012-2020 28
Figure 5: Cardiac Assist Procedures, United States, Historic, 2005-2012 30
Figure 6: Cardiac Assist Procedures, United States, Forecast, 2012-2020 32
Figure 7: Ventricular Assist Devices (VAD) Procedures, United States, Historic, 2005-2012 34
Figure 8: Ventricular Assist Devices (VAD) Procedures, United States, Forecast, 2012-2020 36
Figure 9: Cardiac Rhythm Management (CRM) Procedures, United States, Historic, 2005-2012 38
Figure 10: Cardiac Rhythm Management (CRM) Procedures, United States, Forecast, 2012-2020 40
Figure 11: Implantable Cardioverter Defibrillator (ICD) Procedures, United States, Historic, 2005-2012 42
Figure 12: Single Chamber ICD Procedures, United States, Historic, 2005-2012 44
Figure 13: Dual Chamber ICD Procedures, United States, Historic, 2005-2012 46
Figure 14: Cardiac Resynchronisation Therapy (CRT) Procedures, United States, Historic, 2005-2012 48
Figure 15: CRT - Defibrillator Implant Procedures, United States, Historic, 2005-2012 50
Figure 16: CRT - Pacemaker Implant Procedures, United States, Historic, 2005-2012 52
Figure 17: Pacemaker Implant Procedures, United States, Historic, 2005-2012 54
Figure 18: Single chamber Pacemaker Implant Procedures, United States, Historic, 2005-2012 56
Figure 19: Dual chamber Pacemaker Implant Procedures, United States, Historic, 2005-2012 58
Figure 20: Implantable Loop Recorder (ILR) Procedures, United States, Historic, 2005-2012 60
Figure 21: Implantable Cardioverter Defibrillator (ICD) Procedures, United States, Forecast, 2012-2020 62
Figure 22: Single Chamber ICD Procedures, United States, Forecast, 2012-2020 64
Figure 23: Dual Chamber ICD Procedures, United States, Forecast, 2012-2020 66
Figure 24: Cardiac Resynchronisation Therapy (CRT) Procedures, United States, Forecast, 2012-2020 68
Figure 25: CRT - Defibrillator Implant Procedures, United States, Forecast, 2012-2020 70
Figure 26: CRT - Pacemaker Implant Procedures, United States, Forecast, 2012-2020 72
Figure 27: Pacemaker Implant Procedures, United States, Forecast, 2012-2020 74
Figure 28: Single chamber Pacemaker Implant Procedures, United States, Forecast, 2012-2020 76
Figure 29: Dual chamber Pacemaker Implant Procedures, United States, Forecast, 2012-2020 78
Figure 30: Implantable Loop Recorder (ILR) Procedures, United States, Forecast, 2012-2020 80
Figure 31: Septal Occluders, United States, Historic, 2005-2012 82
Figure 32: Septal Occluders, United States, Forecast, 2012-2020 84
Figure 33: Cardiovascular Surgery, United States, Historic, 2005-2012 86
Figure 34: Cardiovascular Surgery, United States, Forecast, 2012-2020 88
Figure 35: Coronary Artery Bypass Graft Procedures (CABG), United States, Historic, 2005-2012 90
Figure 36: On Pump Procedures, United States, Historic, 2005-2012 92
Figure 37: Coronary Artery Bypass Graft Procedures (CABG), United States, Forecast, 2012-2020 94
Figure 38: On Pump Procedures, United States, Forecast, 2012-2020 96
Figure 39: Electrophysiology Ablation Procedures, United States, Historic, 2005-2012 98
Figure 40: Electrophysiology Ablation Procedures, United States, Forecast, 2012-2020 99
Figure 41: Interventional Cardiology Procedures, United States, Historic, 2005-2012 100
Figure 42: Interventional Cardiology Procedures, United States, Forecast, 2012-2020 102
Figure 43: Coronary Stenting Procedures, United States, Historic, 2005-2012 104
Figure 44: Coronary Stenting Procedures, United States, Forecast, 2012-2020 106
Figure 45: Bare Metal Coronary Stenting Procedures, United States, Historic, 2005-2012 108
Figure 46: Drug Eluting Coronary Stenting Procedures, United States, Historic, 2005-2012 110
Figure 47: Bare Metal Coronary Stenting Procedures, United States, Forecast, 2012-2020 112
Figure 48: Drug Eluting Coronary Stenting Procedures, United States, Forecast, 2012-2020 114
Figure 49: Peripheral Vascular Procedures, United States, Historic, 2005-2012 116
Figure 50: Peripheral Vascular Procedures, United States, Forecast, 2012-2020 119
Figure 51: Peripheral Vascular Stenting Procedures, United States, Historic, 2005-2012 122
Figure 52: Iliac Artery Stenting Procedures, United States, Historic, 2005-2012 124
Figure 53: Femoropopliteal Artery Stenting Procedures, United States, Historic, 2005-2012 126
Figure 54: Infrapopliteal Artery Stenting Procedures, United States, Historic, 2005-2012 128
Figure 55: PTA Balloon Angioplasty Procedures, United States, Historic, 2005-2012 130
Figure 56: Aortic Stent Graft Procedures, United States, Historic, 2005-2012 132
Figure 57: Aortic Open Repair Procedures, United States, Historic, 2005-2012 134
Figure 58: Peripheral Bypass Procedures, United States, Historic, 2005-2012 136
Figure 59: PTA Drug Eluting Balloons (DEB) Angioplasty Procedures, United States, Forecast, 2012-2020 138
Figure 60: Peripheral Vascular Stenting Procedures, United States, Forecast, 2012-2020 140
Figure 61: Iliac Artery Stenting Procedures, United States, Forecast, 2012-2020 142
Figure 62: Femoropopliteal Artery Stenting Procedures, United States, Forecast, 2012-2020 144
Figure 63: Infrapopliteal Artery Stenting Procedures, United States, Forecast, 2012-2020 146
Figure 64: PTA Balloon Angioplasty Procedures, United States, Forecast, 2012-2020 148
Figure 65: Aortic Stent Graft Procedures, United States, Forecast, 2012-2020 150
Figure 66: Aortic Open Repair Procedures, United States, Forecast, 2012-2020 152
Figure 67: Peripheral Bypass Procedures, United States, Forecast, 2012-2020 154
Figure 68: Prosthetic Heart Valve Procedures, United States, Historic, 2005-2012 156
Figure 69: Prosthetic Heart Valve Procedures, United States, Forecast, 2012-2020 158
Figure 70: Conventional Aortic Valve Replacement Procedures, United States, Historic, 2005-2012 160
Figure 71: Conventional Mitral Valve Procedures, United States, Historic, 2005-2012 162
Figure 72: Conventional Aortic Valve Replacement Procedures, United States, Forecast, 2012-2020 164
Figure 73: Conventional Mitral Valve Procedures, United States, Forecast, 2012-2020 166
Figure 74: GlobalData Epidemiology-Based Forecasting Model 173
Figure 75: GlobalData Capital Equipment-Based Forecasting Model 174
Figure 76: Primary Interviews by Participant Type (%) 175

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • China Interventional Cardiovascular Device Industry Report, 2014-2017
    Published: 27-Sep-2014        Price: US $2200 Onwards        Pages: 112
    The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing year after year, thereby promoting the development of domestic percutaneous coronary intervention (PCI) market. PCI cases in China totaled 454,505 in 2013, up 16.9% from a year earlier; meanwhile the interventional cardiovascular device industry there was worth RMB20.12 billion. At present, half of......
  • Global Heart Valve Repair and Replacement Market 2014-2018
    Published: 20-Aug-2014        Price: US $2500 Onwards        Pages: 78
    Heart valves are structures in the human heart which control the flow of blood during the cardiac cycle. A person affected with heart valve diseases such as valvular stenosis, valvular insufficiency or regurgitation, prolapse, and atresia requires the repair or replacement of the natural heart valves. Aortic valves cannot be repaired; therefore, it is replaced using prosthetic heart valves. However, the mitral, tricuspid, and pulmonary valves can be repaired as well as replaced depending on the ......
  • Global Heart Defect Closure Devices Market 2014-2018
    Published: 6-Aug-2014        Price: US $2500 Onwards        Pages: 70
    Heart defect closure devices are used for the treatment of several CHDs. The heart closure devices help when closing the ostium/ hole/ deficiency in the structure of the heart present in the septal walls or blood vessels that occurs in the patients with CHDs. CHD is an anomaly in the structure of the heart present at the time of birth, which are among the most common types of birth defects. Some of the CHDs include ASD, PFO, VSD, PDA and LAA. These defects cause disruption of the normal flow of ......
  • Global Cardiac POC Market 2014-2018
    Published: 6-Aug-2014        Price: US $2500 Onwards        Pages: 63
    Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes and heart failure. These tests help in the detection of enzymes released during failure of the heart and in critical cardiac conditions such as crea......
  • Ventilators Market to 2020 – Technical Advances and Hospital Expansion Serve as Distinct Regional Growth Drivers
    Published: 4-Aug-2014        Price: US $3500 Onwards        Pages: 74
    GBI Research’s report, “Ventilators Market to 2020 Technical Advances and Hospital Expansion Serve as Distinct Regional Growth Drivers” discusses the market, competitive landscape, and trends for three ventilator market segments: Adult/pediatric, neonatal and transport ventilators.It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the market. The report also reviews the competitive landscape, analyzes pipeline pro......
  • Market Research Report on Global and Chinese Cold Pressor Industry, 2009-2019
    Published: 1-Aug-2014        Price: US $2400 Onwards        Pages: 150
    Market Research Report on Global and Chinese Cold Pressor Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Cold Pressor industry. The report firstly reviews the basic information of Cold Pressor including its classification, application and manufacturing technology; The report then explores global and China's top manufacturers of Cold Pressor listing their product specification, capacity, Production value, and market share etc.; The report further analyzes q......
  • Cardiovascular Devices Markets in China
    Published: 1-Aug-2014        Price: US $4000 Onwards        Pages: 207
    China's demand for Cardiovascular Devices has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profil......
  • EU: Pacemakers For Stimulating Heart Muscles (Excl. Parts And Accessories) – Market Report. Analysis and Forecast to 2020
    Published: 1-Aug-2014        Price: US $1250 Onwards        
    "Report will be delivered within 4-5 working days" The report provides an in-depth analysis of the EU Market of Pacemakers For Stimulating Heart Muscles (Excl. Parts And Accessories). It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of key factors influencing the market......
  • Prosthetic Heart Valves – Global Trends, Estimates and Forecasts, 2012-2018
    Published: 30-Jun-2014        Price: US $4450 Onwards        Pages: 514
    Global Market Watch: The Cardiac Prosthetic Heart Valves market value is expected to reach US$2.9 billion by 2016, primarily supported by the product types - Mechanical Heart Valves, Transluminal Heart Valves and Tissue Heart Valves. Geographical analysis for Cardiac Prosthetic Heart Valves market shows that the highest Compounded Annual Growth Rate (CAGR) of 10.8% is anticipated from Asia-Pacific region during the analysis period 2012-2018. Globally, Mechanical Heart Valves account for appro......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs